Mr. Chen, 62, once considered giving up due to unbearable chemotherapy side effects.
After receiving CIK adjunctive therapy, his physical strength gradually recovered.
He said: "I used to have no strength to even eat. Now I can accompany my grandson to the park every day, watching him run and play—this is my greatest miracle."

This three-year follow-up study shows that 82% of patients experienced enhanced activity of key NK immune cells after treatment.
These results have been published in international authoritative journals, demonstrating the safety and potential of this protocol.